Literature DB >> 12968881

Synthesis of various 3-substituted 1,2,4-oxadiazole-containing chiral beta 3- and alpha-amino acids from Fmoc-protected aspartic acid.

Abdallah Hamzé1, Jean-François Hernandez, Pierre Fulcrand, Jean Martinez.   

Abstract

Various 3-substituted chiral 1,2,4-oxadiazole-containing Fmoc-beta(3)- and -alpha-amino acids were synthesized from Fmoc-(l or d)-Asp(OtBu)-OH and Fmoc-l-Asp-OtBu, respectively, in three steps (i.e., condensation of an aspartyl derivative with differentially substituted amidoximes, formation of the 1,2,4-oxadiazole, and cleavage of the tert-butyl ester). These compounds represent new series of nonnatural amino acids, which could be used in combinatorial synthesis. A simple protocol has been developed to generate the 1,2,4-oxadiazole ring. Indeed, common methods resulted in cleavage of the Fmoc group or required long reaction times. We found that sodium acetate in refluxing ethanol/water (86 degrees C) was a convenient and efficient catalyst to promote conversion of Fmoc-amino acyl amidoximes to 1,2,4-oxadiazoles, and this procedure proved to be compatible with Fmoc protection. It is shown that these compounds can be prepared without significant loss of enantiomerical purity. Furthermore, the alkaline conditions used to cleave the Fmoc protecting group from these compounds did not induce epimerization of their chiral center.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12968881     DOI: 10.1021/jo0345953

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  5 in total

1.  Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii.

Authors:  Christopher P Hencken; Lorraine Jones-Brando; Claudia Bordón; Remo Stohler; Bryan T Mott; Robert Yolken; Gary H Posner; Lauren E Woodard
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

2.  Synthesis of 2-(1,2,4-oxadiazol-3-yl)quinazolin-4(3H)-ones from diaminoglyoxime-based nitrones.

Authors:  Rahim Hosseinzadeh-Khanmiri; Abolghasem Moghimi; Ahmad Shaabani; Hassan Valizadeh; Seik Weng Ng
Journal:  Mol Divers       Date:  2015-04-22       Impact factor: 2.943

3.  Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonists.

Authors:  Mark E Layton; Michael J Kelly; Kevin J Rodzinak; Philip E Sanderson; Steven D Young; Rodney A Bednar; Anthony G Dilella; Terrence P McDonald; Hao Wang; Scott D Mosser; John F Fay; Michael E Cunningham; Duane R Reiss; Christine Fandozzi; Nicole Trainor; Annie Liang; Edward V Lis; Guy R Seabrook; Mark O Urban; James Yergey; Kenneth S Koblan
Journal:  ACS Chem Neurosci       Date:  2011-04-15       Impact factor: 4.418

4.  Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs.

Authors:  Frank W Foss; Thomas P Mathews; Yugesh Kharel; Perry C Kennedy; Ashley H Snyder; Michael D Davis; Kevin R Lynch; Timothy L Macdonald
Journal:  Bioorg Med Chem       Date:  2009-04-12       Impact factor: 3.641

5.  Function-Oriented Synthesis of Marine Phidianidine Derivatives as Potential PTP1B Inhibitors with Specific Selectivity.

Authors:  Jin Liu; Yu Chen; Jing-Ya Li; Cheng Luo; Jia Li; Kai-Xian Chen; Xu-Wen Li; Yue-Wei Guo
Journal:  Mar Drugs       Date:  2018-03-20       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.